• WKN: A3CNK4
  • ISIN: DE000A3CNK42
  • Land: Deutschland


Notiert in Frankfurter Wertpapierbörse 
Index SDAX® 
Letzte Dividende  

Aktuelle Aktionärsstruktur

Michael Otto Stiftung and Prof. Dr. Michael Otto1 36.4 %
Anders Holch Povlsen2 19.7 %
Benjamin Otto3 7.1 %
Tarek Müller4 3.0 %
Sebastian Betz5 2.6 %
Hannes Wiese6 1.7 %
Treasury shares 8.5 %
Other shareholders 1.8 %
Public float7 19.2 %

1 Otto (GmbH & Co KG)
2 Aktieselskabet af 12.6.2018
3 GFH Gesellschaft für Handelsbeteiligungen m.b.H
4 Tarek Müller Beteiligungsgesellschaft mbH
5 Sebastian Betz Beteiligungsgesellschaft mbH
6 Hannes Wiese Beteiligungsgesellschaft mbH
7 Der Streubesitz gemäß Definition der Deutschen Börse AG beträgt 21%, nach Ablauf der Sperrfrist der anderen Aktionäre

Stand Struktur 15. Juni 2021

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

Aktuelle Research-Studie

Original-Research: Gold Mountain Mining Corp. (von hanseatic stock publishing UG (haftungsbeschränkt)): Gold Mountain Mining Corp.

29. November 2021